FDA.reportPublic FDA data

NDC 66621-0150-1 - ANASCORP

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
66621-0150
Requested NDC
66621-0150-1
Package NDCs from labels
66621-0150-1, 66621-0150-2
Manufacturer
Rare Disease Therapeutics, Inc | Laboratorios Silanes S.A. de C.V.
Effective date
2025-07-16
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
ANASCORP - Rare Disease Therapeutics, Inc | Laboratorios Silanes S.A. de C.V.Rare Disease Therapeutics, Inc | Laboratorios Silanes S.A. de C.V.2025-07-16PLASMA DERIVATIVE
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
66621-0150-1ANASCORP10 mL in 1 VIALINJECTION, POWDER, LYOPHILIZED,1020
66621-0150-2ANASCORP1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,120

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
66621-0150ANASCORP (CENTRUROIDES (SCORPION) IMMUNE F(AB)2 (EQUINE)) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [RARE DISEASE THERAPEUTICS, INC]19Current NDC, Legacy NDC, 2 package rows20240517_5cb65048-a30c-48e5-8bc8-897983d08068.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
66621-0150-1EA - Each66621-0150c1b5574c-e204-4436-8ecb-4d6e932832ec12012-07-24
66621-0150-2EA - Each66621-01507fff0a50-b77a-4f63-a823-597245b414fd12017-08-11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
CENTRUROIDES FAB2 ANTIVENIN (EQUINE)ACTIVE INGREDIENTDDA050FCEAANASCORP (CENTRUROIDES (SCORPION) IMMUNE F(AB)2 (EQUINE)) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [RARE DISEASE THERAPEUTICS, INC]3
CENTRUROIDES FAB2 ANTIVENIN (EQUINE)ACTIVE MOIETYDDA050FCEAANASCORP (CENTRUROIDES (SCORPION) IMMUNE F(AB)2 (EQUINE)) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [RARE DISEASE THERAPEUTICS, INC]3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1af197eb-94a9-449a-9667-1e3911255e435cb65048-a30c-48e5-8bc8-897983d080682013-12-04Warnings, Adverse reactionsExact identifier
spl set id: 5cb65048-a30c-48e5-8bc8-897983d08068

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.